At 16.2% CAGR, Europe Electronic Patient-Reported Outcomes (ePROS) Market is Projected to be Worth US$ 889.08 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the Europe electronic patient-reported outcomes (ePROS) market was valued at US$ 268.32 million in 2023 and is expected to reach US$ 889.08 million by 2031, registering a CAGR of 16.2% from 2023 to 2031. Rising adoption of telehealth and remote monitoring and increasing focus on patient-centered care are among the critical factors attributed to drive the Europe electronic patient-reported outcomes (ePROS) market growth.

The market for electronically reported patient outcomes (ePROs) is expected to experience lucrative opportunities with the rising adoption of telehealth and remote monitoring for clinical trials during the forecast period. Patients in remote or underserved areas can report real-time information from the comfort of their homes owing to telehealth and remote monitoring solutions, which increase accessibility of patient data. Health data can be continuously transmitted via remote monitoring devices, such as wearables and linked health systems. When coupled with ePRO systems, medical professionals receive detailed information regarding a patient's condition in real time, enabling more precise and regular interventions. For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care.

On the contrary, data privacy and security issues hamper the growth of Europe electronic patient-reported outcomes (ePROS) market.

By delivery mode, the Europe electronic patient-reported outcomes (ePROS) market is bifurcated into cloud based and on-premises. The cloud based segment held 56.0% share of Europe electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 150.14 million. It is projected to garner US$ 494.27 million by 2031 to register 16.1% CAGR during 2023-2031.

In terms of application, the Europe electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held 67.4% share of Europe electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 180.90 million. It is projected to garner US$ 615.60 million by 2031 to register 16.5% CAGR during 2023-2031.

By end user, the Europe electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held 56.2% share of Europe electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 150.90 million. It is projected to garner US$ 497.98 million by 2031 to register 16.1% CAGR during 2023-2031.

Based on country, the Europe electronic patient-reported outcomes (ePROS) market is categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.5% share of Europe electronic patient-reported outcomes (ePROS) market in 2023. It was assessed at US$ 79.21 million in 2023 and is likely to hit US$ 261.03 million by 2031, registering a CAGR of 16.1% during 2023-2031.

Key players operating in the Europe electronic patient-reported outcomes (ePROS) market are Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC, among others.

August 2024, Clinical Ink launched EDCXtra, an innovative Electronic Data Capture (EDC) system. EDCXtra incorporates all existing DDC functionality into a single web-based application which includes Clinical ink's industry leading electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions, providing a comprehensive, all-in-one GCP compliant platform.


Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com